Commitments and Contingencies (Narrative) (Details) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | 12 Months Ended | |||
---|---|---|---|---|---|---|
Feb. 07, 2025 |
Jun. 30, 2025 |
Jun. 30, 2024 |
Jun. 30, 2025 |
Jun. 30, 2024 |
Dec. 31, 2022 |
|
Loss Contingencies [Line Items] | ||||||
Acquired in-process research and development expense | $ 5,000 | $ 0 | ||||
Purchase commitment | $ 3,375 | $ 3,362 | 7,487 | $ 6,149 | ||
Long-term purchase commitment, period | 10 years | |||||
SentreHEART v Atricure | ||||||
Loss Contingencies [Line Items] | ||||||
Damages sought | $ 260,000 | |||||
Cooperation Agreement | ||||||
Loss Contingencies [Line Items] | ||||||
Contingent consideration, maximum payout | 28,000 | |||||
Acquired in-process research and development expense | $ 5,000 | $ 5,000 |
X | ||||||||||
- Definition Asset Acquisition, Contingent Consideration, Range Of Outcomes, Maximum No definition available.
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The value (monetary amount) of the award the plaintiff seeks in the legal matter. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Amount of writeoff for research and development asset acquired in transaction other than business combination or from joint venture formation or both. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The amount purchased during the period under an unrecorded unconditional purchase obligation (for example, under the take-or-pay or throughput contract). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Term of the unrecognized unconditional purchase obligation, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|